Latest news
Loading news…
cCAM Biotherapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Qiryat Shmona, HaZafon, Israel Founded 2009 11-50 employees For Profit
cCAM Biotherapeutics is a pre-clinical stage company that develops immunotherapies for cancer.
cCAM Biotherapeutics was acquired by Merck in 2015 for $95M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 16
- Active products
- 7
- Patents granted
- 7
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2009
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 2
- HQ
- Qiryat Shmona, HaZafon, Israel
- Region
- Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
- Exit date
- Jul 28, 2015
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 3.8
- Trend (90d)
- -0.1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to cCAM Biotherapeutics
Loading news…
FAQs about cCAM Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.